Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study-Reference-Cited by-同舟云学术

Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study

Published:2015-10-09 Issue:6 Volume:100 Page:787-795
ISSN:0007-1161
Container-title:British Journal of Ophthalmology
language:en
Short-container-title:Br J Ophthalmol

Author:

Prünte Christian,Fajnkuchen Franck,Mahmood Sajjad,Ricci Federico,Hatz Katja,Studnička Jan,Bezlyak Vladimir,Parikh Soumil,Stubbings William John,Wenzel Andreas,Figueira João,

Publisher

BMJ

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference24 articles.

1. Visual impairment in diabetes;Klein;Ophthalmology,1984

2. Diabetic retinopathy;Antonetti;N Engl J Med,2012

3. Burden of illness of diabetic macular edema: literature review;Chen;Curr Med Res Opin,2010

4. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema;Mitchell;Ophthalmology,2011

5. Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: Interim analysis of the RESTORE Extension Study;Lang;Ophthalmology,2013

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema;JAMA Ophthalmology;2024-09-12

2. Résultats anatomiques et fonctionnels du protocole thérapeutique « 3 + PRN » dans le traitement de l’œdème maculaire diabétique;Journal Français d'Ophtalmologie;2024-09

3. One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity;Ophthalmology Retina;2024-09

4. Real-World Efficacy of Intravitreal Faricimab for Diabetic Macular Edema: A Systematic Review;Journal of Personalized Medicine;2024-08-28

5. Vitrectomy as an Adjunct to Treat-and-Extend Anti-VEGF Injections for Diabetic Macular Edema;JAMA Ophthalmology;2024-08-08